Form 4: Humacyte Executive Acquires Stock Options
SEC Filing
Heather Ledbetter Prichard, Chief Operating Officer of Humacyte, Inc., acquired stock options on January 21, 2025.
Summary
- Heather Ledbetter Prichard, the Chief Operating Officer of Humacyte, Inc., filed a Form 4.
- The filing reports a transaction involving derivative securities.
- Prichard acquired 283,101 stock options with an exercise price of $4.56 on January 21, 2025.
- The options become exercisable starting January 21, 2026, with full vesting by January 21, 2029.
- The expiration date for these options is January 21, 2035.
- Following the transaction, Prichard directly owns 283,101 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and potential alignment with shareholder interests.
Stakeholder Impact
- The acquisition of stock options by a key executive can signal confidence in the company's future prospects, potentially impacting shareholder sentiment positively.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of the stock option acquisition. |
| 01/21/2026 | First vesting date for the stock options (25%). |
| 01/21/2029 | Final vesting date for the stock options. |
| 01/21/2035 | Expiration date of the stock options. |
| 01/23/2025 | Date of the Form 4 filing. |
Keywords
Form 4, Humacyte, Stock Options, Insider Trading, Executive Compensation, Securities, Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.